Have a prescription? Buy Cabometyx from Canada and experience the following benefits:

  • Cost Savings: Significantly Lower Prices compared to the US.
  • Bulk Discounts: Save More on Quantity (Limit: 90-day supply).
  • Express Ships from Canada: Fast & Efficient Shipping Directly to your Doorstep.
  • Secure Ordering: Order Cabometyx Online or by Phone at 1-888-513-2294
  • SAVE 10% on first order with code: FIRST10
Buy Cabometyx from Canada
CABOMETYX
Cabozantinib
Select product strength & quantity:
Select product strength & quantity:
Select product strength & quantity:

Prescription Required.

Product of Canada.

Shipped from Canada.

Prescription Required.Product of Canada.Shipped from Canada.

What is Cabometyx?

Cabometyx is the brand name for cabozantinib, a powerful kinase inhibitor used in cancer treatment. Pronounced as “ka-boh-MEH-tiks,” this medication falls under the category of tyrosine kinase inhibitors (TKIs). TKIs are a type of targeted cancer therapy that works by blocking specific enzymes, known as tyrosine kinases, which are involved in the growth and spread of cancer cells. By inhibiting these enzymes, Cabometyx effectively slows down or stops the progression of cancer, making it a crucial option for patients with certain types of advanced cancers.

Medical Uses

Cabometyx has been approved for the treatment of several types of advanced cancers, each with its unique challenges and treatment needs:

  • Advanced Renal Cell Carcinoma: Cabometyx is used for the treatment of advanced kidney cancer, particularly in cases where the disease has progressed despite previous treatment.
  • Hepatocellular Carcinoma: For patients with liver cancer who have previously been treated with sorafenib, Cabometyx offers a new line of treatment.
  • Differentiated Thyroid Cancer: In cases of thyroid cancer that has spread and cannot be treated with radioactive iodine, or where the disease has progressed after treatment with a VEGFR-targeted therapy, Cabometyx provides an effective treatment option.

In each of these scenarios, Cabometyx plays a critical role in managing the disease, offering patients a chance for improved outcomes and quality of life.

How Cabometyx Works

Cabometyx, known generically as cabozantinib, operates as a potent kinase inhibitor, specifically targeting tyrosine kinases. These kinases play a crucial role in the growth and spread of cancer cells. Cabometyx’s mechanism of action involves blocking these protein kinases, particularly those involved in angiogenesis (the formation of new blood vessels), which tumors need for growth and metastasis. By inhibiting these kinases, Cabometyx effectively disrupts the pathways that cancer cells use to grow, divide, and spread. This action makes it a valuable treatment option for certain types of advanced cancers, including renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid cancer, by slowing down their progression and potentially reducing tumor size.

Dosage and Administration

Cabometyx is available in tablet form and comes in various strengths, allowing for dosage flexibility based on the patient’s medical condition and treatment response. The recommended dosage and administration of Cabometyx depend on factors such as the type and severity of the cancer being treated, the patient’s overall health, and their response to the therapy. It’s typically taken once daily, with or without food. Patients are advised to follow their healthcare provider’s instructions closely regarding dosage and administration. Due to the potential for serious side effects, it’s important for patients to adhere strictly to the prescribed dosage and schedule and to discuss any concerns or side effects with their healthcare provider. Regular monitoring and adjustments may be necessary to optimize treatment efficacy and minimize adverse reactions.

Side Effects of Cabometyx

The administration of Cabometyx (cabozantinib) can lead to a range of side effects, varying in severity and impact on patients. Understanding these side effects is crucial for both healthcare providers and patients to manage and mitigate potential risks effectively.

Common Side Effects

Patients taking Cabometyx may experience several common side effects, which, while generally manageable, can affect quality of life and treatment adherence. These include:

  • Diarrhea: A frequent side effect that can range from mild to severe. Patients are advised to stay hydrated and may require medical intervention if symptoms persist.
  • Fatigue: Feelings of tiredness and weakness are common, which can impact daily activities. Adequate rest and adjustments in daily routines may be necessary.
  • Decreased Appetite: Patients may experience a reduction in their desire to eat, which can lead to weight loss and nutritional deficiencies. Dietary modifications and nutritional supplements might be recommended.

Serious Side Effects

In addition to common side effects, Cabometyx can cause more severe adverse reactions that require immediate medical attention, including:

  • High Blood Pressure (Hypertension): This can be a significant issue requiring monitoring and possibly medication to control. Symptoms like severe headaches, dizziness, or changes in vision should be reported immediately.
  • Severe Bleeding: Patients may experience serious bleeding events. Signs of unusual bleeding, such as blood in stools or urine, coughing up blood, or unexplained bruising, should be promptly addressed.

Long-term Risks and Considerations

Long-term use of Cabometyx necessitates careful monitoring due to the potential for lasting side effects. These may include:

  • Liver Function Alterations: Regular liver function tests are recommended as Cabometyx can affect liver enzymes and overall liver health.
  • Risk of Secondary Cancers: As with many cancer treatments, there may be a risk, albeit small, of developing secondary malignancies.
  • Cardiovascular Health: Long-term use may impact heart health, necessitating regular cardiovascular assessments.

Patients on Cabometyx should have regular follow-up appointments to monitor for these side effects and adjust treatment as necessary. It’s important for patients to report any new or worsening symptoms to their healthcare provider promptly. This proactive approach helps in minimizing the risk of adverse reactions and ensures the effective management of the patient’s condition.

Warnings and Precautions for Cabometyx

The use of Cabometyx (cabozantinib) requires careful consideration due to its potential to cause serious and sometimes life-threatening side effects. Understanding these risks is crucial for both healthcare providers and patients to ensure safe and effective treatment.

Risks Associated with Cabometyx

  • Hemorrhage: Cabometyx has been associated with severe hemorrhage, including fatal bleeding incidents. Patients should be monitored for signs of bleeding and informed about the importance of reporting any symptoms such as unusual bruising or bleeding.
  • Gastrointestinal Perforations and Fistulas: There have been reports of gastrointestinal perforations and fistulas in patients taking Cabometyx. Patients should be advised to report any severe abdominal pain immediately.
  • Thrombotic Events: Cabometyx can increase the risk of thrombotic events like heart attack or stroke. Patients with a history of these conditions should use Cabometyx with caution.
  • Hypertension and Hypertensive Crisis: Elevated blood pressure is a common occurrence with Cabometyx. Blood pressure should be well-controlled prior to initiating treatment, and monitoring should continue throughout therapy.
  • Palmar-Plantar Erythrodysesthesia Syndrome: Also known as hand-foot syndrome, this condition can occur with Cabometyx, leading to redness, swelling, and pain on the palms of the hands or soles of the feet.

Precautions for Specific Patient Populations

  • Hepatic Impairment: Patients with pre-existing liver conditions should be closely monitored, as Cabometyx can affect liver function.
  • Renal Impairment: Renal function should be assessed prior to and during treatment, as Cabometyx can impact kidney health.
  • Pregnancy and Breastfeeding: Cabometyx can harm a fetus and should not be used during pregnancy. Women of childbearing potential should use effective contraception during treatment and for a specified period after the last dose. Breastfeeding is not recommended during treatment and for a certain time after the final dose.

Drug Interactions

  • CYP3A4 Inhibitors and Inducers: Cabometyx is metabolized by CYP3A4. The use of inhibitors or inducers of this enzyme can alter the concentration of Cabometyx in the body, potentially affecting its efficacy and safety.

Administration Precautions

  • Dosage Adjustments: Dosage adjustments may be necessary based on individual tolerance and response to treatment, as well as the occurrence of adverse reactions.
  • Patient Education: Patients should be thoroughly educated about the potential side effects of Cabometyx and the importance of adhering to prescribed dosages and schedules.

While Cabometyx offers significant therapeutic benefits in treating certain types of cancer, its use is accompanied by serious risks that require vigilant monitoring and prompt management. Healthcare providers play a crucial role in educating patients, monitoring for side effects, and implementing appropriate interventions to ensure patient safety during Cabometyx treatment.

Interactions with Other Medications

The treatment with Cabometyx (cabozantinib) necessitates a comprehensive understanding of its potential interactions with other medications. These interactions can significantly impact the effectiveness of the treatment and the patient’s overall safety.

Comprehensive Medication Disclosure

  • Full Medication List: Patients are advised to provide their healthcare providers with a complete list of all medications they are currently taking. This includes not only prescription drugs but also over-the-counter medicines, vitamins, and herbal supplements. The reason for this thorough disclosure is that Cabometyx can interact with other medications, potentially leading to increased side effects or reduced effectiveness of the treatment.
  • Importance of Accuracy: Accurate and complete information about all medications is crucial for healthcare providers to make informed decisions about the use of Cabometyx and to manage potential drug interactions effectively.

Known Drug Interactions

  • CYP3A4 Inhibitors and Inducers: Cabometyx is metabolized primarily by the CYP3A4 enzyme. Therefore, drugs that inhibit or induce this enzyme can affect the levels of Cabometyx in the body. Strong CYP3A4 inhibitors can increase Cabometyx concentrations, potentially leading to more side effects, while inducers can decrease its concentrations, possibly reducing its efficacy.
  • Effect on Other Drugs: Cabometyx may also affect the metabolism of other drugs, especially those that are substrates of CYP3A4. This can alter the effectiveness and safety profile of those medications.
  • Anticoagulants and Antiplatelet Agents: Given the risk of bleeding with Cabometyx, caution is advised when it is used in combination with anticoagulants or antiplatelet agents.

Special Considerations

  • Monitoring and Adjustments: Patients using Cabometyx alongside other medications that can affect or be affected by it should be closely monitored. This includes regular blood tests to check drug levels and adjusting dosages as necessary.
  • Patient Education: Patients should be educated about the potential for drug interactions and advised to inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. They should also be aware of the signs and symptoms of adverse drug interactions.

Managing interactions with other medications is a critical aspect of Cabometyx treatment. Patients must be proactive in disclosing all medications they are taking and adhere to guidelines regarding potential interactions. Healthcare providers play a key role in monitoring these interactions to ensure the safe and effective use of Cabometyx.

Use in Specific Populations

The administration of Cabometyx (cabozantinib) requires careful consideration of the patient’s overall health and specific medical history. This is particularly important due to the medication’s potent mechanism of action and the potential for serious side effects.

Considerations for Different Patient Groups

  • Patients with Pre-existing Conditions: Individuals with a history of liver or kidney problems, cardiovascular diseases, or gastrointestinal disorders should use Cabometyx with caution. The drug’s effects on these conditions need careful monitoring.
  • Elderly Patients: Older patients may have a different response to Cabometyx, potentially requiring dose adjustments and closer monitoring due to the increased likelihood of coexisting medical conditions and other medication use.

Use During Pregnancy and Breastfeeding

  • Pregnancy: Cabometyx is not recommended for use during pregnancy. It falls under FDA pregnancy category D, indicating there is positive evidence of human fetal risk. Women of childbearing age should be advised to use effective contraception during treatment and for a specified period after the last dose.
  • Breastfeeding: Due to the potential for serious adverse reactions in nursing infants, breastfeeding is not recommended during treatment with Cabometyx and for a certain time after the final dose. The decision to discontinue breastfeeding or the drug should be made considering the importance of the drug to the mother.

Pediatric Use

  • Children and Adolescents: The safety and effectiveness of Cabometyx in pediatric patients have not been established. Its use in children should be based on a careful consideration of the potential risks and benefits.

Patients with Renal or Hepatic Impairment

  • Renal Impairment: Patients with pre-existing renal conditions should be closely monitored during treatment with Cabometyx, as it can affect renal function.
  • Hepatic Impairment: Similarly, those with liver impairment may require dose adjustments and regular liver function testing, as Cabometyx can impact liver enzymes and overall liver health.

The use of Cabometyx in specific populations requires a thorough evaluation of the patient’s medical history, current health status, and future plans regarding pregnancy and breastfeeding. This comprehensive approach ensures that the treatment is not only effective but also safe for the patient’s specific circumstances. Regular monitoring and follow-up are essential to manage any emerging side effects or complications effectively.

Patient Education and Support for Cabometyx

Patient education and support are crucial components of the treatment process with Cabometyx (cabozantinib), especially given the complexity of the medication and its potential side effects. Ensuring that patients are well-informed and supported throughout their treatment journey can significantly impact the effectiveness of the therapy and the patient’s overall experience.

Importance of Patient Education

  • Understanding the Medication: Patients should be provided with comprehensive information about Cabometyx, including how it works, its intended benefits, and potential side effects. Understanding the medication can help patients recognize why adherence is crucial and what to expect during treatment.
  • Managing Side Effects: Educating patients about common and serious side effects is vital. They should know how to identify symptoms that require immediate medical attention and understand the importance of regular monitoring and follow-up appointments.
  • Lifestyle Considerations: Patients should receive guidance on lifestyle adjustments that may help manage side effects, such as dietary changes to cope with gastrointestinal issues or strategies to combat fatigue.

Support Resources

  • Access to Resources: Providing patients with access to additional resources, such as patient support groups, counseling services, and educational materials, can offer further guidance and support. These resources can help patients feel more empowered and less isolated in their treatment journey.
  • Communication with Healthcare Providers: Encouraging open and ongoing communication between patients and their healthcare team is essential. Patients should feel comfortable discussing their symptoms, treatment experiences, and any concerns they may have.

Adherence to Treatment

  • Importance of Adherence: Patients should be educated about the importance of adhering to the prescribed treatment regimen, including dosage and administration guidelines. Understanding the consequences of non-adherence can motivate patients to follow their treatment plan closely.
  • Handling and Storage: Proper handling and storage of Cabometyx are important for maintaining its efficacy. Patients and caregivers should be instructed on how to store and handle the medication correctly.

Navigating Treatment Decisions

  • Informed Decision-Making: Patients should be involved in their treatment decisions, understanding the risks and benefits of Cabometyx. This collaborative approach can help ensure that the treatment plan aligns with the patient’s preferences and goals.

Effective patient education and support are integral to the successful management of cancer treatment with Cabometyx. By providing the necessary information, resources, and encouragement, healthcare providers can help patients navigate their treatment with confidence and a better understanding of their therapy.

Frequently Asked Questions

Cabometyx is used to treat certain types of cancer, including advanced kidney cancer (renal cell carcinoma), liver cancer (hepatocellular carcinoma), and differentiated thyroid cancer that has spread and cannot be treated with radioactive iodine.

Cabometyx works by inhibiting multiple tyrosine kinases, proteins that contribute to tumor growth, angiogenesis (formation of new blood vessels that tumors need to grow), and metastatic progression of cancer.

Individuals with a known allergy to cabozantinib or any of its components should not use Cabometyx. Patients with certain pre-existing conditions should consult their doctor before starting treatment.

Common side effects include diarrhea, fatigue, decreased appetite, nausea, hand-foot syndrome, high blood pressure, vomiting, weight loss, and constipation.

Yes, serious side effects can include severe bleeding, holes in the stomach or intestines, blood clots, stroke, heart attack, and high blood pressure.

Cabometyx can harm a fetus and is not recommended during pregnancy. Women of childbearing age should use contraception during treatment and for a period after the last dose.

It is not known if Cabometyx passes into breast milk. Breastfeeding is not recommended during treatment and for a period after the final dose.

Cabometyx is taken orally, with the dosage and administration depending on the type and severity of the cancer being treated.

Avoid grapefruit, grapefruit juice, and St. John’s wort as they can affect how Cabometyx works. Also, avoid activities that can lead to bleeding or injury.

Yes, Cabometyx can cause liver problems. Patients should have liver function tests before and during treatment.

Hand-foot syndrome is a skin reaction causing redness, pain, and swelling in the palms of the hands or soles of the feet.

Yes, inform your healthcare provider about all medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Cabometyx may affect fertility in both males and females and may affect your ability to have children.

Store Cabometyx at room temperature, away from moisture and heat, and keep it out of reach of children.

Regularly monitor blood pressure, complete blood counts, and liver and kidney function. Report any symptoms of bleeding, headache, seizure, or confusion immediately.

Patients with high blood pressure should have it well-controlled before starting Cabometyx and should monitor it regularly during treatment.

If you miss a dose, take it as soon as you remember. If it’s close to your next dose, skip the missed dose. Do not take two doses at the same time.

Yes, Cabometyx can cause changes in thyroid hormone levels. Your healthcare provider will do blood tests to check your thyroid function before and during treatment.

Is there financial assistance available for Cabometyx? Financial assistance programs may be available for eligible patients. Consult the Cabometyx website or your healthcare provider for more information.

How does Cabometyx interact with other cancer treatments? Cabometyx may interact with other cancer treatments. Discuss with your healthcare provider about any other cancer therapies you are undergoing.